Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Conference News HVS 2025

Solid Durability Seen With Surgical Resilia Tissue Aortic Valve

Yael L. Maxwell

April 21, 2025

News Features

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

Yael L. Maxwell

March 27, 2025

News Conference News NY Valves 2024

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

Michael O'Riordan

June 11, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

News Conference News STS 2024

SAVR After Failed TAVI on the Rise, With High Mortality

Yael L. Maxwell

February 05, 2024

News Daily News

Socioeconomics Mire Access to All AVR Options for Aortic Stenosis

Yael L. Maxwell

January 22, 2024

News Daily News

Ross Procedure Offers ‘Excellent Survival’ 25 Years Out

Caitlin E. Cox

November 15, 2023

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

News Daily News

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

Michael O'Riordan

April 27, 2023

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

News Daily News

Psychosocial Risk Affects AVR Recovery, Merits Heart Team Consideration

L.A. McKeown

November 24, 2022

News Conference News TCT 2022

Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning

Shelley Wood

September 19, 2022

News Conference News STS 2022

Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database

L.A. McKeown

February 02, 2022

News Daily News

Valve-in-Valve TAVI Bests Redo SAVR in Short Term

Michael O'Riordan

September 20, 2021

News Daily News

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

L.A. McKeown

July 27, 2020

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

Presentation TVT 2020

Outcomes of Surgical Explantation of TAVR– A Population-Based, Nationally-Representative Analysis

Presenter: Tsuyoshi Kaneko

June 21, 2020

Presentation TVT 2020

Valve-in-Surgical Valve with SAPIEN 3 for Transcatheter Aortic Valve Replacement:Propensity-Matched Analyses of Real World Data Based on the STS Predicted Risk of Mortality

Presenter: Tsuyoshi Kaneko

June 20, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Daily News

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

Yael L. Maxwell

September 18, 2019

Advertisement

Solid Durability Seen With Surgical Resilia Tissue Aortic Valve

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

SAVR After Failed TAVI on the Rise, With High Mortality

Socioeconomics Mire Access to All AVR Options for Aortic Stenosis

Ross Procedure Offers ‘Excellent Survival’ 25 Years Out

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Psychosocial Risk Affects AVR Recovery, Merits Heart Team Consideration

Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning

Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database

Valve-in-Valve TAVI Bests Redo SAVR in Short Term

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

Device Explants After TAVR Rare but Risky

Outcomes of Surgical Explantation of TAVR– A Population-Based, Nationally-Representative Analysis

Valve-in-Surgical Valve with SAPIEN 3 for Transcatheter Aortic Valve Replacement:Propensity-Matched Analyses of Real World Data Based on the STS Predicted Risk of Mortality

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content